| Role |
Name |
Disclosure |
Details |
| Author | Ronald A Greenfield, MD, Professor, Chief, Department of Internal Medicine, Section of Infectious Diseases, University of Oklahoma College of Medicine | Pfizer Gilead Ortho McNeil Wyeth Abbott Astellas Cubicin | Details | | Medical Editor | Thomas J Marrie, MD, Chair, Professor, Department of Medicine, Division of Infectious Diseases, University of Alberta College of Medicine | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | John W King, MD, Professor of Medicine, Section of Infectious Diseases, Louisiana State University Health Sciences Center; Director, Viral Therapeutics Clinics for Hepatitis; Consulting Staff, Department of Infectious Diseases, Overton Brook Veterans Affairs Medical Center | emedicine | Details | | CME Editor | Eleftherios Mylonakis, MD, Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital | Nothing to disclose | Details | | Chief Editor | Burke A Cunha, MD, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Thomas J Marrie, Medical Editor |
The contributor discloses no conflict of interest. |
|